Adverse events ( AEs ) reported at a higher incidence in the rotigotine @ mg/@ h group versus placebo included application site reactions , nausea , dry mouth , and dyskinesia ; there was no worsening of insomnia , somnolence , orthostatic hypotension , confusional state or hallucinations , even in patients @ years of age .